动态液相微萃取GC/MS-SIM方法检验毛发中的苯丙胺类毒品

建立了动态液相微萃取GC/MS-SIM方法检测毛发中4种苯丙胺类毒品的方法.毛发样品首先用1 mol/L NaOH溶液消解,然后用50μL氯仿涡旋提取1min,离心后用注射器直接抽取有机相,提取液进行GC/MS-SIM方法检测.毛发样品的测出限(S/N=3)分别为苯丙胺1 ng/mg,甲基苯丙胺、3、4-(亚甲二氧基)苯丙胺、3、4(亚甲二氧基)-甲基苯丙胺500 pg/mg.在毛发中添加上述4种苯丙胺毒品的质量分数为5 ng/mg时,5次测定的RSD分别为苯丙胺8.3%,甲基苯丙胺8.2%,3、4-(亚甲二氧基)苯丙胺2.0%,3、4(亚甲二氧基)2.7%.该方法可用于毛发中低含量苯丙胺类毒品的分析.     

海洛因与甲基苯丙胺毒品滥用者毛发特征分析的比较

根据海洛因和甲基苯丙胺滥用者毛发中毒品及其代谢物的分布特点,通过实验比较了两类毒品滥用者毛发的分析特点。海洛因吸食者毛发采用甲醇超声释放待测物,而后直接调整pH值进行液相萃取,萃取物挥干后进行衍生化并进行GC/MS检测;甲基苯丙胺吸食者毛发在碱性条件下消解,然后采用小体积萃取,直接在提取液中衍生化,并进行GC/MS检测。通过空白毛发标准添加6-单乙酰吗啡、吗啡和可待因进行分析,3种鸦片类毒品最小检测限均小于3μg/g,RSD(n=5)为2.5%~9.6%;通过空白毛发标准添加苯丙胺、甲基苯丙胺、3,4-(亚甲二氧基)苯丙胺和3,4-(亚甲二氧基)-甲基苯丙胺进行分析,4种苯丙胺类毒品的最小检测限为0.05μg/g,RSD(n=5)为5%~14%。     

海洛因与甲基苯丙胺毒品滥用者毛发特征分析的比较

根据海洛因和甲基苯丙胺滥用者毛发中毒品及其代谢物的分布特点,通过实验比较了两类毒品滥用者毛发的分析特点。 海洛因吸食者毛发采用甲醇超声释放待测物,而后直接调整pH值进行液相萃取,萃取物挥干后进行衍生化并进行GC/MS检测;甲基苯丙胺吸食者毛发在碱性条件下消解,然后采用小体积萃取,直接在提取液中衍生化,并进行GC/MS检测。 通过空白毛发标准添加6-单乙酰吗啡、吗啡和可待因进行分析,3种鸦片类毒品最小检测限均小于 3 μg/g,RSD(n=5)为2.5%~9.6%;通过空白毛发标准添加苯丙胺、甲基苯丙胺、3,4-(亚甲二氧基)苯丙胺和3,4-(亚甲二氧基)-甲基苯丙胺进行分析,4种苯丙胺类毒品的最小检测限为0.05 μg/g,RSD(n=5)为5%~14%。     

唾液中苯丙胺类毒品的液相小体积萃取GC/MS-SIM检测

建立了一种便捷的唾液中4种毒品(苯丙胺(AM)、甲基苯丙胺(MAM)、3,4-(亚甲二氧基)苯丙胺(MDA)、3,4(亚甲二氧基)-甲基苯丙胺(MDMA))的液相小体积超声提取-气相色谱/质谱-选择离子检测分析方法并考察了小体积萃取溶剂和体积对萃取效果的影响.该方法用100μL环己烷对唾液中的毒品进行提取,直接抽取提取液用气相色谱/质谱-选择离子(GC/MS-SIM)检测,获得良好线性,相对标准偏差在15%内,准确性均在80%～120%之间,最小检测限可达0.1μg/mL.该方法灵敏、简便、快速,可用于缴获毒品及嫌疑吸毒者人体生物检材中苯丙胺类毒品的分析.     

中空纤维膜液相微萃取-气相色谱/质谱法检测尿液中的苯丙胺类兴奋剂

建立了尿液中痕量苯丙胺类毒品的中空纤维膜液相微萃取-气相色谱/质谱检测方法。采用中空纤维膜液相微萃取技术萃取尿液中4种苯丙胺类毒品,研究萃取剂类型、体积、溶液pH、萃取时间和温度等对萃取效果的影响。尿液中4种苯丙胺类毒品的最佳萃取条件为:样品溶液pH 13,甲苯为萃取剂,搅拌速度500 r/min,30℃条件下萃取15 min;此条件下苯丙胺(AM)、甲基苯丙胺(MAM)、3,4-亚甲二氧基苯丙胺(MDA)、3,4-亚甲二氧基甲基苯丙胺(MDMA)的检出限(S/N=3)分别为1.0,0.75,1.0,0.64 ng/mL,相对标准偏差分别为6.62%,3.98%,4.57%,2.35%,富集倍数分别为155,170,132,218倍。本方法可用于尿液中痕量苯丙胺类毒品的分析测定。     

唾液中苯丙胺类毒品的毛细管区带电泳在线富集检测

采用毛细管区带电泳(CZE)中的场放大样品堆积(FASS)技术对唾液中的苯丙胺类毒品进行了检测.采用含30%(体积分数)甲醇的100mmol/L磷酸盐(pH3.0)为分离缓冲液,用水溶解样品,利用缓冲体系与样品溶液体系电导率的差异,在毛细管中浓缩样品组分,对苯丙胺(AM)、甲基苯丙胺(MAM)、3,4-(亚甲二氧基)苯丙胺(MDA)、3,4-(亚甲二氧基)甲基苯丙胺(MDMA)4种毒品进行了分离和定量测定.采用利多卡因为内标,对添加上述4种毒品的唾液进行液液提取并进行FASS-CZE检测,可检测到的上述毒品质量浓度为0.002mg/L,与常规毛细管区带电泳比较,灵敏度提高上千倍;相对标准偏差在1.4%～7.7%之间,回收率在74%～108%.该方法可用于生物检材中苯丙胺类毒品的检测.     

场放大样品堆积毛细管区带电泳检测尿液中苯丙胺类毒品

建立了毛细管区带电泳(CZE)中场放大样品堆积(FASS)技术分析尿液中苯丙胺类毒品的方法。采用体积分数30%甲醇的100 mmol/L磷酸盐(pH 3)为分离缓冲液,利用缓冲体系与样品溶液体系电导率的差异,在毛细管中浓缩样品组分,对苯丙胺、甲基苯丙胺、3,4-(亚甲二氧基)苯丙胺(MDA)、3,4-(亚甲二氧基)甲基苯丙胺(MDMA)4种毒品进行了分离和定量测定,与常规毛细管区带电泳比较,检测灵敏度提高约2000倍。采用利多卡因为内标,对添加上述4种毒品的尿液进行提取和测定,分析的相对标准偏差在15%范围之内,可检测到的上述毒品质量浓度为0.002μg/mL,相对回收率在70%~120%内。该方法可用于生物检材中苯丙胺类毒品的检测。     

在线样品浓缩毛细管区带电泳分析毛发中的苯丙胺类毒品

建立了毛细管区带电泳(CZE)的在线场放大样品堆积(FASS)方法。采用含有40%乙烯乙二醇的100 mmol/L磷酸盐二元缓冲液(pH 2.5),80%异丙醇的0.1 mmol/L磷酸样品溶液,利用缓冲体系与样品溶液体系电导率的差异,在毛细管中浓缩样品组分,对苯丙胺、甲基苯丙胺、亚甲基二氧基苯丙胺(MDA)、亚甲基二氧基甲基苯丙胺(MDMA)4种毒品进行了分离和定量测定,检测的灵敏度提高约1000倍。对于标准品的检出限可达到0.06μg/L。当样品浓度高于5μg/L时,分析的相对标准偏差在10%范围之内;用该方法对添加毒品的毛发进行了提取和测定,可检测到的添加浓度为1μg/g毛发。该方法可用于生物检材中苯丙胺类毒品的检测。     

超声液相萃取-GC/MS-SIM法定量检测唾液中苯丙胺类毒品

建立了一种人体唾液中苯丙胺(AM)、甲基苯丙胺(MAM)、 3, 4-亚甲二氧基苯丙胺(MDA)、 3, 4-亚甲二氧基甲基苯丙胺(MDMA)毒品的超声波液液萃取-气相色谱/质谱-选择离子检测方法. 对萃取溶剂、萃取时间等参数进行了考查, 确定了乙酸乙酯为萃取溶剂, 在超声波下液液萃取2 min. 用该溶剂对添加毒品的唾液进行提取, 采用气相色谱/质谱-选择离子检测法(GC/MS-SIM)检测, 获得了良好线性, 相对标准偏差在15%内, 准确性均在80%～115%之间, 最小检测限可达0.05 μg/mL. 该方法未对毒品进行衍生化处理, 可用于缴获毒品及嫌疑吸毒者人体生物检材中苯丙胺类毒品的分析.     

微波萃取-气相色谱法测定尿液中的苯丙胺类毒品

建立了人体尿液中甲基苯丙胺(MA)、3,4-亚甲二氧基苯丙胺(MDA)、3,4-亚甲二氧基甲基苯丙胺(MDMA)的微波萃取-气相色谱(GC)测定方法。分别考察了萃取溶剂种类、用量、pH值以及萃取温度、时间等因素对萃取率的影响。实验结果表明,尿液中MA,MDA,MDMA的最佳提取条件为:调节尿样pH为12,以环己烷为萃取溶剂,于40 ℃下微波提取10 min。在此条件下MA,MDA,MDMA的平均回收率分别为92.25%,85.94%和91.50%,相对标准偏差分别为5.5%,5.5%和6.1% (n=5),提取液经气相色谱-氢火焰离子化检测器(GC-FID)检测,3种药物与基体得到了很好的分离,对尿液中MA,MDA,MDMA的最低检测限分别为10,20和20 ng/mL。该方法未对药物进行衍生化,是一种快速、准确、灵敏度高的同时测定尿液中MA,MDA,MDMA的方法。     

生物样品中苯丙胺类毒品的小体积液相萃取及GC/MS分析

小体积液相萃取;苯丙胺毒品;唾液;毛发;GC/MS     

High-performance liquid chromatography with fluorescence detection for the simultaneous determination of 3,4-methylenedioxymethamphetamine, methamphetamine and their metabolites in human hair using DIB-Cl as a label

This paper describes a highly sensitive HPLC method for the simultaneous determination of 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA), amphetamine (AP) and methamphetamine (MP) in human hair samples. The amphetamines investigated were derivatized with the fluorescent reagent, DIB-Cl to yield highly fluorescent DIB-derivatives, which were then analyzed by HPLC with fluorescence detection at excitation and emission wavelengths of 325 nm and 430 nm, respectively. The separation was achieved on an ODS column with an isocratic mobile phase composed of acetonitrile-methanol-water (30:40:30, v/v/v). The limits of detection for the four compounds obtained by the proposed method ranged from 11 to 200 pg/mg. The method was successfully applied to the determination of MDMA and MDA in hair samples obtained from MDMA abuser.     

Simultaneous quantitative determination of amphetamines, ketamine, opiates and metabolites in human hair by gas chromatography/mass spectrometry

A gas chromatography/mass spectrometry (GC/MS) method was developed and validated for the determination of common drugs of abuse in Asia. The method was able to simultaneously quantify amphetamines (amphetamine; AP, methamphetamine; MA, methylenedioxy amphetamine; MDA, methylenedioxymeth mphetamine; MDMA, methylenedioxy ethylamphetamine; MDEA), ketamine (ketamine; K, norketamine; NK), and opiates (morphine; MOR, codeine; COD, 6-acetylmorphine; 6-AM) in human hair. Hair samples (25 mg) were washed, cut, and incubated overnight at 25 degrees C in methanol/trifluoroacetic acid (methanol/TFA). The samples were extracted by solid-phase extraction (SPE), derivatized using heptafluorobutyric acid anhydride (HFBA) at 70 degrees C for 30 min, and the derivatives were analyzed by electron ionization (EI) GC/MS in selected ion monitoring mode. Confirmation was accomplished by comparing retention times and the relative abundances of selected ions with those of standards. Deuterated analogs of the analytes were used as internal standards for quantification. Calibration curves for ten analytes were established in the concentration range 0.1-10 ng/mg with high correlation coefficients (r2 > 0.999). The intra-day and inter-day precisions were within 12.1% and 15.8%, respectively. The intra-day and inter-day accuracies were between -8.7% and 10.7%, and between -5.9% and 13.8%, respectively. The limit of detection (LOD) and limit of quantification (LOQ) obtained were 0.03 and 0.05 ng/mg for AP, MA, MDA, MDMA and MDEA; 0.05 and 0.08 ng/mg for K, NK, MOR and COD; and 0.08 and 0.1 ng/mg for 6-AM. The recoveries were above 88.6% for all the compounds, except K and NK which were in the range of 71.7-72.7%. Eight hair samples from known polydrug abusers were examined by this method. These results show that the method is suitable for broad-spectrum drug testing in a single hair specimen.     

Quantification of MDMA and MDA in abusers' hair samples by semi-micro column HPLC with fluorescence detection

A sensitive semi-micro column high-performance liquid chromatography with fluorescence detection method was developed for the determination of 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA), methamphetamine (MP) and amphetamine (AP) in human hair. 4-(4,5-Diphenyl-1H-imidazol-2-yl)benzoyl chloride (DIB-Cl) and 1-methyl-3-phenylpropylamine were used as labeling reagent and internal standard, respectively. These drugs were extracted from hair into 5% trifluoroacetic acid in methanol, and fluorescent labeled with DIB-Cl. The separation of DIB-derivatives was achieved on a reversed-phase semi-micro ODS column with an acetonitrile-methanol-water (30:40:30, v/v/v%) mixture as a mobile phase. The limits of detection at a signal-to-noise ratio of 3 for MDMA, MDA, MP and AP were 0.25, 0.15, 0.25 and 0.19 ng/mg, respectively. Precision of intra- and inter-day assay as the relative standard deviation were in the range 1.5-6.8% (n = 5) and 2.7-4.7% (n = 5), respectively. The proposed method was highly sensitive and able to detect MDMA and its related compounds in small amounts of hair sample, and could be applied to quantification of six abusers' hair samples.     

Determination of ketamine and amphetamines in hair by LC/MS/MS

A liquid chromatography-tandem mass spectrometry method was developed for the determination of ketamine (with its metabolite norketamine) and some amphetamines (amphetamine, methamphetamine, methylenedioxyamphetamine, and 3,4-methylenedioxymethamphetamine). This method was developed to determine these compounds in hair and is able to simultaneously quantify all of them in human hair. Hair samples (20 mg) were washed and pulverized, and an extraction with formic acid (0.01%) and ultrasonication for 4 h was used. Deuterated analogs of the analytes were used as internal standards for quantification. Linearity from 0.5 to 25 ng/mg was obtained for both ketamine (and norketamine) and amphetamines with correlation coefficients exceeding 0.99. The limit of detection and the limit of quantification obtained were 0.1 and 0.5 ng/mg, respectively, for ketamine and amphetamines. A total of 25 hair samples from known drug abusers (relating to designer drug consumption or consumption of amphetamines) were examined by this validated method. The results show that the proposed method is suitable for testing these drugs in a single sample of hair. In addition, it is simpler and faster than analysis by conventional methods such as gas chromatography-mass spectrometry, which usually require a more laborious extraction procedure and, in most of cases, an additional derivatization process.     

Development of a simultaneous analytical method for selected anorectics,methamphetamine, MDMA,and their metabolites in hair using LC-MS/MS to prove anorectics abuse

Owing to the tight control of methamphetamine, it is presumed that phentermine, an amphetamine-type anorectic, has recently been considered a supplement for methamphetamine abusers in Korea. In addition, the abuse of other anorectics obtained by inappropriate means has become a social issue. Hair is a useful specimen to prove chronic drug use. Therefore, an analytical method for the simultaneous detection of phentermine, phendimetrazine, amfepramone, fenfluramine, mazindol, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA), as well as their metabolites, which covers the major amphetamines and anorectic agents in Korea, in hair was established and validated using liquid chromatography–tandem mass spectrometry (LC-MS/MS). The drugs and their metabolites in hair were extracted using 1 % HCl in methanol and then filtered and analyzed by LC-MS/MS with electrospray ionization in positive mode. The validation results for selectivity, linearity, matrix effect, recovery, process efficiency, intra- and interassay precision and accuracy, and processed sample stability were satisfactory. The limits of detection ranged from 0.025 to 1 ng/10 mg hair and the limits of quantification were 0.25 ng/10 mg hair for every analyte except mazindol and phentermine, for which they were 10 ng/10 mg hair. The method was successfully applied for the segmental determination of selected anorectics, methamphetamine, MDMA, and their metabolites in hair from 39 drug suspects. Among the anorectics, phentermine and/or phendimetrazine were identified with or without methamphetamine in the hair samples. Closer supervision of the inappropriate use of anorectics is necessary. Also, hair analysis is useful for monitoring the abuse potential of unnoticed drugs.     

Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry

In forensic toxicology, hair analysis has become a well established analytical strategy to investigate retrospectively drug abuse histories. In this field, gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry are currently used, often after preliminary screening with immunoassays. However, on the basis of previous applications to pharmaceutical analysis, capillary zone electrophoresis coupled to ion trap mass spectrometry looks also highly promising. The purpose of the present work was the development of a simple and rapid CZE-MS method for sensitive and quantitative determination of the main drugs of abuse and their metabolites (namely, 6-monoacetylmorphine, morphine, amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethampthetamine (MDMA), benzoylecgonine, ephedrine and cocaine) in human hair. Hair samples (100 mg) were washed, cut and incubated overnight in 0.1 M HCl at 45 degrees C, then neutralized with NaOH and extracted by a liquid-liquid extraction method. CZE separations were carried out in a 100 cm x 75 microm (I.D.) uncoated fused silica capillary. The separation buffer was composed of 25 mM ammonium formate, pH 9.5; the separation voltage was 15 kV. Electrokinetic injections were performed at 7 kV for 30 s under field amplified sample stacking conditions. ESI-ion trap MS detection was performed in the ESI positive ionization mode using the following conditions: capillary voltage 4 kV, nebulizer gas (nitrogen) pressure 3psi, source temperature 150 degrees C and drying gas (nitrogen) flow rate 8l/min. A sheath liquid, composed of isopropanol-water (50:50, v/v) with 0.5% formic acid, was delivered at a flow rate of 4 microl/min. The ion trap MS operated in a selected ion monitoring mode (SIM) of positive molecular ions for each drug/metabolite. Collision induced fragmentation was also possible. Nalorphine was used as internal standard. Under the described conditions, the separation of all compounds, except amphetamine/methamphetamine, MDA/MDMA and morphine/6-MAM was achieved in 20 min, with limits of detection lower than the most severe cut-offs adopted in hair analysis (i.e. 0.1 ng/mg). Linearity was assessed within drug concentration ranges from 0.025 to 5 ng of each analyte/mg of hair. Analytical precision was fairly acceptable with RSD's < or = 3.06% for migration times and < or = 22.47% for areas in real samples, in both intra-day and day-to-day experiments. On these grounds, the described method can be proposed for rapid, selective and accurate toxicological hair analysis for both clinical and forensic purposes.     

Simultaneous determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography/mass spectrometry

A gas chromatography/mass spectrometric (GC/MS) method was developed and validated for the determination of thirteen psychotropic phenylalkylamine derivatives (amphetamine; AP, phentermine; PT, methamphamine; MA, cathinone; Khat, methcathinone; MCAT, fenfluramine; FFA, desmethylselegiline; DSEL, 3,4-methylenedioxyamphetamine; MDA, 3,4-methylenedioxymethamphetamine; MDMA, 3,4-methylenedioxyethylamphetamine; MDEA, norketamine; NKT, mescaline; MES, 4-bromo-2,5-dimethoxyphenethylamine; 2CB) in human hair. Hair samples (20 mg) were washed with distilled water and acetone, cut into small fragments (<1 mm), and incubated in 0.25 M methanolic HCl under ultrasonication at 50 degrees C for 1 h. The resulting solutions were evaporated to dryness, derivatized using trifluoroacetic anhydride (TFAA) at 70 degrees C for 30 min, and analyzed by GC/MS. The linear ranges were 0.02-25.0 ng/mg for AP, PT, Khat, FFA, DSEL, MDMA, and 2CB; 0.05-25.0 ng/mg for MA, MCAT, and MES; 0.05-12.5 ng/mg for MDA; and 0.1-25.0 ng/mg for MDEA and NKT, with good correlation coefficients (r(2) > 0.9985). The intra-day, inter-day, and inter-person precisions were within 12.7%, 14.8%, and 16.8%, respectively. The intra-day, inter-day, and inter-person accuracies were between -10.7 and 13.4%, -12.7 and 11.6%, and -15.3 and 11.9%, respectively. The limits of quantifications (LOQs) for each compound were lower than 0.08 ng/mg. The recoveries were in the range of 76.7-95.6%. The method proved to be suitable for the simultaneous qualification and quantification of phenylalkylamine derivatives in hair specimens.     

Sensitive determination of MDMA and its metabolite MDA in rat blood and brain microdialysates by HPLC with fluorescence detection

Simultaneous determination of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in rat blood and brain microdialysates by high-performance liquid chromatography with fluorescence detection (HPLC-FL) was developed. Microdialysates were directly subjected to derivatization with 4-(4,5-diphenyl-1H-imidazol-2-yl)benzoyl chloride (DIB-Cl). The DIB-derivatives of MDMA, MDA and the internal standard, 1-methyl-3-phenylpropylamine (MPPA), were isocratically separated on an ODS column using a mixture of 50 mm phosphate buffer (pH 7.0)-acetonitrile-methanol-2-propanol (50:45:5:2, v/v/v/v %) as an eluent at a flow rate of 1.5 mL/min. The calibration curves of MDA and MDMA spiked to blood and brain microdialysates were linear over the ranges 2.5-500 and 5.0-1000 ng/mL, respectively. The detection limits of MDA and MDMA were 1.2 and 4.2 for blood and 1.3 and 4.8 ng/mL for brain, respectively. Additionally, the intra- and the inter-assay precisions were lower than 5.6% for the blood and brain microdialysates (n = 4). The proposed method was successfully applied for the monitoring of MDMA and its metabolite MDA in rat blood and brain microdialysates, and the pharmacokinetic parameters of MDMA and MDA in the microdialysates after administration of MDMA (5 mg/kg, i.p.) with or without caffeine (20 mg/kg, i.p.) were evaluated.